These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1949739)
21. [The immunological reactivity of patients with acute odontogenic inflammatory diseases]. Robustova TG; Biberman IaM; Starodubtsev VS; Shaĭdullin MS; Kostishin ID Voen Med Zh; 1990 Sep; (9):52-4. PubMed ID: 2264305 [No Abstract] [Full Text] [Related]
22. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer]. Volosevich LI; Lukach EV; Krivokhatskaia LD Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382 [TBL] [Abstract][Full Text] [Related]
24. [A system of individual immunotherapy with leakadin in the combined therapy of acoustic neurinomas]. Starchenko AA; Khil'ko VA; Komarets SA; Khlunovskiĭ AN; Prilukova TI; Kraskovskaia SV; Danilov AV Zh Vopr Neirokhir Im N N Burdenko; 1996; (4):15-8. PubMed ID: 9092246 [TBL] [Abstract][Full Text] [Related]
25. [Cytostatic treatment of polycythemia vera with a methylbenzylhydrazine derivative]. Martin H; Schubert JC Dtsch Med Wochenschr; 1966 Jan; 91(2):55-7. PubMed ID: 5900941 [No Abstract] [Full Text] [Related]
26. [Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine]. Gorshkova NI; Samsonov VA; Mazina NM; Parastaev SA Vestn Dermatol Venerol; 1989; (9):6-10. PubMed ID: 2609769 [TBL] [Abstract][Full Text] [Related]
27. [T- and B-cellular immunity system in thyrotoxicosis patients treated with thyrostatic preparations]. Kabatsiĭ NP Vrach Delo; 1984 Feb; (2):80-2. PubMed ID: 6202062 [No Abstract] [Full Text] [Related]
28. [Disordered immunologic reactivity in patients with chronic calculous cholecystitis]. Koval'chuk LA; Venger IK; Piatnochka VI Klin Khir (1962); 1989; (9):6-7. PubMed ID: 2593528 [TBL] [Abstract][Full Text] [Related]
29. [Trial to influence polycythemia with erythrocyte-antibodies. I. Preliminary clinical results]. Hrubisko M; Fãbryovã L; Lipsic T Vnitr Lek; 1971 Sep; 17(9):879-87. PubMed ID: 5129135 [No Abstract] [Full Text] [Related]
30. [Therapy of polycythemia vera with busulfan (myleran). Report on results in 40 patients]. Urasiński I; Mysik M Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):360-6. PubMed ID: 4101127 [No Abstract] [Full Text] [Related]
31. [Evaluation of various indicators of cellular immunity in persons exposed to work environment in the Masovian Refinery and Petrochemical Plants in Plock]. Tchórzewski H; Zeman K; Sułowska Z; Baj Z; Rzetelski B; Pacześniak J; Majewska E; Kocur E; Pokoca L; Soszyńska W Med Pr; 1988; 39(2):100-7. PubMed ID: 3264874 [TBL] [Abstract][Full Text] [Related]
32. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester. Pata O; Tok CE; Yazici G; Pata C; Oz AU; Aban M; Dilek S Am J Perinatol; 2004 Apr; 21(3):135-7. PubMed ID: 15085495 [TBL] [Abstract][Full Text] [Related]
33. [On the treatment of hemoblastoses with N-diethyleneimidophosphonyl-N-phenylurea (C 73)]. Gerhartz H; Staeuber PG Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(1):54-61. PubMed ID: 4157882 [No Abstract] [Full Text] [Related]
34. [Dynamics of the immunological reactivity indices in children withh chronic bronchopulmonary processes treated with staphylococcal autovaccine]. Mikheeva GA; Abirov MA Vopr Okhr Materin Det; 1976 Nov; 21(11):48-52. PubMed ID: 1007127 [No Abstract] [Full Text] [Related]
35. [Cytostatic therapy of chronic myelosis and polycythemia vera with myelobromol (dibrommannitol)]. Helbig W; Schwenke H; Müldner J Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(2):182-96. PubMed ID: 4189864 [No Abstract] [Full Text] [Related]
36. Polycythemia vera in a patient with the human immunodeficiency virus: a case report. Sassaki MG; Souza CA; Siciliano RF; Leite AG; Padilha SL Braz J Infect Dis; 2000 Aug; 4(4):204-7. PubMed ID: 11184768 [TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the therapeutic value of mmyeloglobol in polycythemia vera, based on 5-years of obervations]. Szentkláray J Orv Hetil; 1969 Mar; 110(12):651-3. PubMed ID: 5767732 [No Abstract] [Full Text] [Related]
38. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias]. Böhnel J; Stacher A Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360 [No Abstract] [Full Text] [Related]
39. [Immunological reactivity and the nonspecific protection factors in the severe form of tetanus]. Treshchinskiĭ AI; Mozhaev GA; Svirgunenko IuP; Spitsyn ON; Kraevaia SB Anesteziol Reanimatol; 1980 Aug; (4):48-51. PubMed ID: 6968165 [No Abstract] [Full Text] [Related]
40. [T-lymphocyte content in the blood in nephrotuberculosis under antibactertial and immunostimulation therapy]. Mukanbaev K; Vladimirskiĭ MA Probl Tuberk; 1980 Aug; (8):40-2. PubMed ID: 6967603 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]